NRXS witnesses strong revenue growth and expanding coverage in fourth-quarter 2025, but rising costs and commercialization ...

Enrollment underway in FDA-authorized FINALE pivotal trial demonstrating execution toward FemBloc® U.S. approval --ATLANTA, March 31, 2026 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading ...

NeurAxis, Inc. (AMEX:NRXS) Q4 2025 Earnings Call Transcript March 19, 2026 Operator: Ladies and gentlemen, thank you for standing by. Welcome to the NeurAxis, Inc. fourth quarter 2025 financial ...

Bionano Genomics, Inc. (Nasdaq: BNGO) today reported financial results for the fourth quarter and full year ended December 31, 2025. "2025 demonstrated the momentum we built as a business,” commented ...

QT Imaging Holdings, Inc. (Nasdaq: QTI) ("QT Imaging" or the "Company"), a medical device company dedicated to transforming breast health management through innovative, radiation-free imaging ...

Bionano Genomics, Inc. (Nasdaq: BNGO) today reported financial results for the fourth quarter and full year ended December 31, 2025. "2025 demonstrated the ...

Hyperfine, Inc. (NASDAQ:HYPR) Q4 2025 Earnings Call Transcript March 18, 2026 Hyperfine, Inc. beats earnings expectations.

Aerolib launches Aerolib.app for Physician Advisors, featuring P2P simulations, IP-only search tools, & real-time ...

OpenEvidence released an artificial intelligence-powered medical coding feature embedded in its clinical AI assistant. | ...

Corti has launched Symphony for Medical Coding, an agentic AI system built on EMNLP 2025 research that treats coding as a ...

MIAMI, March 26, 2026 /PRNewswire/ -- OpenEvidence, the most widely used medical AI and clinical decision-support platform among U.S. physicians, today announced the launch of Coding Intelligence (TM) ...

Corti, maker of AI foundation models for healthcare, has released a new agentic model for medical coding that it says ...